Meloxicam efficacy and safety in treatment of pain syndromes of different localization according to domestic studies
More than 500 million people worldwide suffer from osteoarthritis (OA). Neck and low back pain (LBP) is one of the most common reasons for visiting a general practitioner to receive primary medical care in different countries. The prevalence of chronic LBP varies from 4% to 20%, and increases linear...
Saved in:
| Main Authors: | O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1716 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meloxicam in rheumatology practice: The history of its use in the therapy of pain
by: L. I. Alekseeva, et al.
Published: (2016-06-01) -
The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs
by: Vladimir Anatol'evich Parfenov, et al.
Published: (2011-06-01) -
AMELOTEX IN THE TREATMENT OF CHRONIC BACK PAIN SYNDROMES
by: Irina Yuryevna Suvorova
Published: (2010-09-01) -
Chronic lower back pain: diagnosis and current principles of therapy
by: V. A. Golovacheva, et al.
Published: (2019-12-01) -
Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01)